Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons

European Journal of Pharmacology

Volumn 356, Issue 2-3, 1998, Pages 255-260

  Lin, Yu ^a   Fossom, Linda H ^b,c   Skolnick, Phil ^b,d   Long, Joseph B ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

ACPC (1 Aminocyclopropanecarboxylic acid); Excitatory amino acid; Excitotoxicity; Glycine; Neuronal injury; Neuroprotection; NMDA (N methyl d aspartate)

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 7 CHLOROKYNURENIC ACID; DIZOCILPINE; EXCITATORY AMINO ACID; EXCITOTOXIN; GLYCINE RECEPTOR AGONIST; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; NERVE CELL CULTURE; NERVE INJURY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0031757901     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00515-9     Document Type: Article

References (20)

1. Boje, K.M., Wong, G., Skolnick, P., 1993. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures. Brain Res. 603, 207.
2. Bovetto, S., Boyer, P.-A., Skolnick, P., Fossom, L.H., 1997. Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs. J. Pharmacol. Exp. Ther. 283, 1503.
3. Chomczynski, P., Sacchi, N., 1987. Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156.
4. Fossom, L.H., Basile, A.S., Skolnick, P., 1995a. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glyine partial agonist, alters N-methyl-D-Aspartate receptor function and subunit composition. Mol. Pharmacol. 48, 981.
5. Fossom, L.H., Von Lubitz, D.K.J.E., Lin, R.C.-S., Skolnick, P., 1995b. Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites. Neurological Res. 17, 265.
6. Globus, M.Y.-T., Busto, R., Martinez, E., Valdes, I., Dietrich, W.D., Ginsberg, M.D., 1991. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and r-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J. Neurochem. 57, 470.
7. Graham, S.H., Shiraishi, K., Simon, S.S., Faden, A.I., 1990. Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci. Lett. 110, 124.
8. Hillered, L., Hallstrom, A., Segersvard, S., Persson, L., Ungerstedt, U., 1989. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral micordialysis. J. Cereb. Blood Flow Metab. 9, 607.
9. Lin, Y., Long, J.B., 1996. Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal cord neurons against NMDA toxicity. Eur. J. Pharmacol. 318, 491.
10. Lin, Y., Long, J.B., 1997. Prolonged pre-exposure to 1-aminocyclopropanecarboxylic acid protects against subsequent glutamate toxicity in vitro. Eur. J. Pharmacol. 338, 289.
11. Long, J.B., Skolnick, P., 1994. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur. J. Pharmacol. 261, 295.
12. Marvizon, J.C.G., Lewin, A., Skolnick, P., 1989. 1-Aminocyclopropanecarboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 52, 992.
13. Nowak, G., Trullas, R., Layerr, R.T., Skolnick, P., Paul, I.A., 1993. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther. 265, 1380.
14. Skolnick, P., Marvizon, J.C.G., Jackson, B.W., Monn, J.A., Rice, K.C., Lewin, A.H., 1989. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45, 1647.
15. Skolnick, P., Miller, R., Young, A., Boje, K., Trullas, R., 1992. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacology 107, 489.
16. Takagi, K.M., Ginsberg, D., Globus, M.Y.-T., Dietrich, W.D., Martinez, E., Kraydieh, S., Busto, R., 1993. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbra region following middle cerebral artery occlusion in the rat: correlation with histopathology. J. Cereb. Blood Flow Metab. 13, 575.
17. Von Lubitz, D.K.J.E., Lin, R.C.-S., McKenhzie, R.J., Devlin, T.M., McCabe, R.T., Skolnick, P., 1992. A novel treatment of global cerebral ischaemia with a glycine partial agonist. Eur. J. Pharmacol. 219, 153.
18. Wafford, K.A., Bain, C.J., Le Bourdelles, B., Whiting, P.J., Kemp, J.A., 1993. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. NeuroReport 4, 1347.
19. Watson, G.B., Lanthorn, T.H., 1990. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29, 727.
20. Zapata, A., Capdevila, J.L., Viu, E., Trullas, R., 1996. 1-Aminocyclopropanecarboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo. NeuroReport 7, 397.